Earnings
RIGL
4.208
+1.64%
0.068
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
22.52M
75.56M
--
10.11M
--
--
0.00
--
1.35M
--
9.46M
--
119.00M
27.87M
--
--
--
--
--
--
696.00K
28.56M
147.57M
--
4.15M
0.00
--
--
--
--
--
28.77M
--
--
--
25.29M
58.21M
9.81M
--
--
--
25.73M
35.54M
93.75M
168.00K
1.33B
-1.28B
--
--
--
53.81M
53.81M
147.57M
FY 2018-12-31
76.32M
52.22M
--
4.08M
--
--
0.00
--
894.00K
--
3.48M
--
136.99M
1.39M
--
--
--
--
--
--
735.00K
2.12M
139.11M
--
6.39M
0.00
--
--
--
--
--
20.31M
--
--
--
1.03M
27.73M
0.00
--
--
--
1.50M
1.50M
29.23M
167.00K
1.32B
-1.21B
--
--
--
109.88M
109.88M
139.11M
FY 2017-12-31
38.29M
77.46M
--
--
--
--
0.00
--
--
--
1.68M
--
117.43M
875.00K
--
--
--
--
--
--
803.00K
1.68M
119.11M
--
2.64M
0.00
--
--
--
--
--
15.42M
--
--
--
284.00K
18.34M
0.00
--
--
--
128.00K
128.00K
18.46M
147.00K
1.24B
-1.14B
--
--
--
100.65M
100.65M
119.11M
FY 2016-12-31
17.63M
57.13M
--
0.00
--
--
0.00
--
--
--
1.45M
--
76.21M
1.16M
--
--
--
--
--
--
764.00K
1.92M
78.13M
--
5.56M
0.00
--
--
--
--
--
11.00M
--
--
--
6.03M
22.59M
0.00
--
--
--
519.00K
519.00K
23.11M
100.00K
1.12B
-1.06B
--
--
--
55.03M
55.03M
78.13M
FY 2015-12-31
43.46M
82.82M
--
203.00K
--
--
0.00
--
--
--
2.54M
--
129.02M
1.61M
--
--
--
--
--
--
1.11M
2.72M
131.75M
--
2.76M
0.00
--
--
--
--
--
12.34M
--
--
--
18.70M
33.80M
0.00
--
--
--
6.57M
6.57M
40.37M
91.00K
1.08B
-991.65M
--
--
--
91.38M
91.38M
131.75M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out RIGL latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Rigel Pharms recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.